Emergent Biosolutions (EBS)

$12.63 +0.09 (0.72%)
Market Cap 658.60M
Revenue (ttm) 1.04B
Net Income (ttm) -190.60M
EPS (ttm) N/A
PE Ratio 6.47
Forward PE 10.77
Profit Margin -18.26%
Debt to Equity Ratio 1.14
Volume 322,000
Avg Vol 1,096,268
Day's Range N/A - N/A
Shares Out 52.52M
Stochastic %K 80%
Beta 2.32
Analysts Strong Sell
Price Target $13.50

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax va...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 631 3200
Address:
300 Professional Drive, Gaithersburg, United States
alwayzwong
alwayzwong Dec. 25 at 4:21 AM
$EBS monthly charts of ‘08 and and this year look eerily similar. ** disclaimer: history doesn’t repeat itself but it often rhymes..
0 · Reply
alwayzwong
alwayzwong Dec. 25 at 2:01 AM
$EBS it won’t end well for shorty
0 · Reply
1iquid
1iquid Dec. 25 at 12:02 AM
💎 Liquid® Live Actionable Trade Asset: $EBS Contracts: $EBS January 15, 2027 $15 Calls Scale in: $2.97- $3.64 Scale out: $11.57-$19.83 Profit Potential : 179% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
Rolltide2020
Rolltide2020 Dec. 24 at 11:44 PM
$EBS Merry Christmas longs and Billiam!!
1 · Reply
ComradeKomisar
ComradeKomisar Dec. 24 at 10:45 PM
$EBS and then some more.
1 · Reply
Daniel3303
Daniel3303 Dec. 24 at 9:42 PM
$EBS Short interest increased to 9M as of 15th Dec. Merry Christmas
1 · Reply
Kazoonova
Kazoonova Dec. 24 at 7:09 PM
$EBS Merry Christmas everyone. Hope everyone is well fed and in good company. See you all on the right side of $13 after the holidays.
0 · Reply
KnuckleSandwich
KnuckleSandwich Dec. 24 at 6:17 PM
$EBS someone likes us at 12.90 in the AH... only 100 shares but gap sure looks nice. 13++ on Friday!
0 · Reply
mhubris
mhubris Dec. 24 at 5:21 PM
$EBS Merry christmas to all EBS warriors that have been here since $2.X USD. Next year will be ours 🤑
1 · Reply
ComradeKomisar
ComradeKomisar Dec. 24 at 5:04 PM
$EBS Not wishing this fella a Merry Christmas.
1 · Reply
Latest News on EBS
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

Dec 12, 2025, 8:30 AM EST - 12 days ago

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

Nov 18, 2025, 8:00 AM EST - 5 weeks ago

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

Nov 12, 2025, 4:01 PM EST - 6 weeks ago

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

Emergent BioSolutions: Solid Q3, Expecting Better Days To Come

Nov 6, 2025, 11:00 PM EST - 6 weeks ago

Emergent BioSolutions: Solid Q3, Expecting Better Days To Come

Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 8:56 PM EDT - 2 months ago

Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 4:15 PM EDT - 2 months ago

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

Oct 28, 2025, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Oct 8, 2025, 7:45 AM EDT - 2 months ago

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

Sep 24, 2025, 4:05 PM EDT - 3 months ago

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

Sep 19, 2025, 8:34 AM EDT - 3 months ago

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

Sep 15, 2025, 8:35 AM EDT - 3 months ago

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

Sep 9, 2025, 7:30 AM EDT - 3 months ago

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Sep 2, 2025, 7:40 AM EDT - 4 months ago

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

Aug 29, 2025, 8:05 AM EDT - 4 months ago

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Aug 27, 2025, 8:01 AM EDT - 4 months ago

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

Aug 21, 2025, 8:45 AM EDT - 4 months ago

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally

Aug 12, 2025, 12:46 PM EDT - 4 months ago

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:31 PM EDT - 4 months ago

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:15 PM EDT - 5 months ago

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

Jul 28, 2025, 8:50 AM EDT - 5 months ago

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Jul 28, 2025, 8:50 AM EDT - 5 months ago

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 15, 2025, 7:30 AM EDT - 5 months ago

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

Jul 8, 2025, 4:45 PM EDT - 6 months ago

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Jul 2, 2025, 4:05 PM EDT - 6 months ago

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Jun 23, 2025, 8:05 AM EDT - 6 months ago

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Jun 20, 2025, 2:25 PM EDT - 6 months ago

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Emergent BioSolutions Announces Addition to Russell 3000® Index

Jun 20, 2025, 8:13 AM EDT - 6 months ago

Emergent BioSolutions Announces Addition to Russell 3000® Index

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Jun 5, 2025, 7:00 AM EDT - 7 months ago

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

May 7, 2025, 10:01 PM EDT - 8 months ago

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

Emergent BioSolutions Reports First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 8 months ago

Emergent BioSolutions Reports First Quarter 2025 Financial Results

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

May 1, 2025, 5:07 PM EDT - 8 months ago

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 22, 2025, 8:00 AM EDT - 8 months ago

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Emergent BioSolutions Announces Stock Repurchase Program

Mar 31, 2025, 8:00 AM EDT - 9 months ago

Emergent BioSolutions Announces Stock Repurchase Program

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Mar 20, 2025, 4:30 PM EDT - 9 months ago

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Mar 20, 2025, 8:06 AM EDT - 9 months ago

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 19, 2025, 4:30 PM EDT - 10 months ago

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Mar 18, 2025, 8:00 AM EDT - 10 months ago

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Mar 13, 2025, 8:29 AM EDT - 10 months ago

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Mar 12, 2025, 8:00 AM EDT - 10 months ago

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 10, 2025, 9:14 AM EDT - 10 months ago

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:58 PM EST - 10 months ago

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 4:23 PM EST - 10 months ago

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 18, 2025, 8:55 AM EST - 11 months ago

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Feb 7, 2025, 8:06 AM EST - 11 months ago

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Jan 16, 2025, 8:00 AM EST - 1 year ago

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Jan 14, 2025, 7:53 AM EST - 1 year ago

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Jan 14, 2025, 7:30 AM EST - 1 year ago

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Jan 13, 2025, 9:27 AM EST - 1 year ago

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Jan 8, 2025, 7:45 AM EST - 1 year ago

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

Jan 8, 2025, 7:30 AM EST - 1 year ago

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

alwayzwong
alwayzwong Dec. 25 at 4:21 AM
$EBS monthly charts of ‘08 and and this year look eerily similar. ** disclaimer: history doesn’t repeat itself but it often rhymes..
0 · Reply
alwayzwong
alwayzwong Dec. 25 at 2:01 AM
$EBS it won’t end well for shorty
0 · Reply
1iquid
1iquid Dec. 25 at 12:02 AM
💎 Liquid® Live Actionable Trade Asset: $EBS Contracts: $EBS January 15, 2027 $15 Calls Scale in: $2.97- $3.64 Scale out: $11.57-$19.83 Profit Potential : 179% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
Rolltide2020
Rolltide2020 Dec. 24 at 11:44 PM
$EBS Merry Christmas longs and Billiam!!
1 · Reply
ComradeKomisar
ComradeKomisar Dec. 24 at 10:45 PM
$EBS and then some more.
1 · Reply
Daniel3303
Daniel3303 Dec. 24 at 9:42 PM
$EBS Short interest increased to 9M as of 15th Dec. Merry Christmas
1 · Reply
Kazoonova
Kazoonova Dec. 24 at 7:09 PM
$EBS Merry Christmas everyone. Hope everyone is well fed and in good company. See you all on the right side of $13 after the holidays.
0 · Reply
KnuckleSandwich
KnuckleSandwich Dec. 24 at 6:17 PM
$EBS someone likes us at 12.90 in the AH... only 100 shares but gap sure looks nice. 13++ on Friday!
0 · Reply
mhubris
mhubris Dec. 24 at 5:21 PM
$EBS Merry christmas to all EBS warriors that have been here since $2.X USD. Next year will be ours 🤑
1 · Reply
ComradeKomisar
ComradeKomisar Dec. 24 at 5:04 PM
$EBS Not wishing this fella a Merry Christmas.
1 · Reply
KnuckleSandwich
KnuckleSandwich Dec. 24 at 3:31 PM
$EBS about to crack the shorts.. see you at 15++
0 · Reply
KnuckleSandwich
KnuckleSandwich Dec. 24 at 3:25 PM
$EBS looking squishy
0 · Reply
GrantDiaz
GrantDiaz Dec. 24 at 3:06 PM
$EBS Nice momentum into year end! Merry Christmas everyone!
1 · Reply
KnuckleSandwich
KnuckleSandwich Dec. 24 at 3:04 PM
$EBS squeeze starts at 13+
0 · Reply
KnuckleSandwich
KnuckleSandwich Dec. 24 at 3:00 PM
$EBS can someone just buy 50K and push it over 13+ to start the squeeze 💥💪🏼
0 · Reply
alwayzwong
alwayzwong Dec. 24 at 2:54 PM
$EBS merry Christmas to all shareholders.
0 · Reply
RedneckHeathen2
RedneckHeathen2 Dec. 24 at 2:42 PM
$EBS Y'all have a good one. Merry Christmas.
0 · Reply
ComradeKomisar
ComradeKomisar Dec. 24 at 2:25 PM
$EBS Merry Christmas one, and all.
0 · Reply
jcwasabi
jcwasabi Dec. 24 at 2:11 PM
$EBS Happy Holidays all. Looking forward to a prosperous new year now that we have as "steady" of an uptrend as we have had in a while...Dollar cost averaging for 2.5 yrs has been interesting given positions between $4-13, but still not day trading this like some of you, so I don't have to invest in proton pump manufacturing companies to heal the ulcers you must all have by now. I still feel sound in my original investment premise with this company, and can just sit back and accumulate more on the dips.
0 · Reply
ComradeKomisar
ComradeKomisar Dec. 24 at 2:44 AM
$EBS Late trade, or late settlement? 🤨
1 · Reply
alwayzwong
alwayzwong Dec. 24 at 1:29 AM
$EBS I’m in the business of investing and making money. The more demand, the better
1 · Reply
WinstonSmith33
WinstonSmith33 Dec. 24 at 1:07 AM
$EBS Yeah, it's a game changer because people are unable to think. Imagine 20 years ago taking pills for weight loss instead of practicing sports or eating a healthy foot.
1 · Reply